NO972434L - Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene - Google Patents

Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene

Info

Publication number
NO972434L
NO972434L NO972434A NO972434A NO972434L NO 972434 L NO972434 L NO 972434L NO 972434 A NO972434 A NO 972434A NO 972434 A NO972434 A NO 972434A NO 972434 L NO972434 L NO 972434L
Authority
NO
Norway
Prior art keywords
naphthoylguanidines
diagnostic
drug
substituted
compounds
Prior art date
Application number
NO972434A
Other languages
English (en)
Other versions
NO972434D0 (no
NO308528B1 (no
Inventor
Joachim Brendel
Heinz-Werner Kleemann
Heinrich Christian Englert
Hans Jochen Lang
Udo Albus
Bansi Lal
Anil Vasantrao Ghate
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO972434D0 publication Critical patent/NO972434D0/no
Publication of NO972434L publication Critical patent/NO972434L/no
Publication of NO308528B1 publication Critical patent/NO308528B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO972434A 1996-05-29 1997-05-28 Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene NO308528B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19621482A DE19621482A1 (de) 1996-05-29 1996-05-29 Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
NO972434D0 NO972434D0 (no) 1997-05-28
NO972434L true NO972434L (no) 1997-12-01
NO308528B1 NO308528B1 (no) 2000-09-25

Family

ID=7795548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972434A NO308528B1 (no) 1996-05-29 1997-05-28 Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene

Country Status (29)

Country Link
US (1) US6600072B2 (no)
EP (1) EP0810205B1 (no)
JP (1) JP4039587B2 (no)
KR (1) KR970074753A (no)
CN (1) CN1062859C (no)
AR (1) AR007299A1 (no)
AT (1) ATE200076T1 (no)
AU (1) AU710258B2 (no)
BR (1) BR9703342A (no)
CA (1) CA2206362C (no)
CZ (1) CZ292441B6 (no)
DE (2) DE19621482A1 (no)
DK (1) DK0810205T3 (no)
ES (1) ES2155223T3 (no)
GR (1) GR3035811T3 (no)
HR (1) HRP970294B1 (no)
HU (1) HUP9700954A3 (no)
ID (1) ID17348A (no)
IL (1) IL120925A0 (no)
NO (1) NO308528B1 (no)
NZ (1) NZ314914A (no)
PL (1) PL185755B1 (no)
PT (1) PT810205E (no)
RU (1) RU2182901C2 (no)
SI (1) SI0810205T1 (no)
SK (1) SK282356B6 (no)
TR (1) TR199700427A2 (no)
TW (1) TW372955B (no)
ZA (1) ZA974664B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
AU2003297629A1 (en) * 2002-12-04 2004-06-23 Ore Pharmaceuticals Inc. Modulators of melanocortin receptor
KR101153254B1 (ko) * 2003-06-26 2012-07-02 바이오트론 리미티드 항바이러스 화합물 및 방법
US20110118262A1 (en) * 2008-07-08 2011-05-19 Boehringer Ingelheim International Gmbh Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4415873A1 (de) 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
JPH08225135A (ja) 1995-02-21 1996-09-03 Mitsubishi Heavy Ind Ltd スクリユ−式土砂搬送機
DE19621483A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AR007299A1 (es) 1999-10-27
KR970074753A (ko) 1997-12-10
CA2206362A1 (en) 1997-11-29
HRP970294B1 (en) 2002-02-28
SK282356B6 (sk) 2002-01-07
JPH1081663A (ja) 1998-03-31
PL318724A1 (en) 1997-12-08
HUP9700954A3 (en) 1998-04-28
NO972434D0 (no) 1997-05-28
US20030013760A1 (en) 2003-01-16
BR9703342A (pt) 1998-08-18
EP0810205A1 (de) 1997-12-03
MX9703921A (es) 1997-11-29
JP4039587B2 (ja) 2008-01-30
EP0810205B1 (de) 2001-03-28
NO308528B1 (no) 2000-09-25
RU2182901C2 (ru) 2002-05-27
CZ163197A3 (cs) 1998-06-17
HUP9700954A2 (hu) 1998-03-02
SK66997A3 (en) 1997-12-10
DE59703220D1 (de) 2001-05-03
CN1167758A (zh) 1997-12-17
ZA974664B (en) 1997-12-01
CA2206362C (en) 2007-11-20
DK0810205T3 (da) 2001-07-16
HRP970294A2 (en) 1998-04-30
US6600072B2 (en) 2003-07-29
CZ292441B6 (cs) 2003-09-17
NZ314914A (en) 1998-02-26
ES2155223T3 (es) 2001-05-01
ID17348A (id) 1997-12-24
GR3035811T3 (en) 2001-07-31
IL120925A0 (en) 1997-09-30
AU2371397A (en) 1997-12-04
PT810205E (pt) 2001-08-30
TW372955B (en) 1999-11-01
SI0810205T1 (no) 2001-06-30
TR199700427A2 (xx) 1997-12-21
DE19621482A1 (de) 1997-12-04
CN1062859C (zh) 2001-03-07
HU9700954D0 (en) 1997-07-28
AU710258B2 (en) 1999-09-16
ATE200076T1 (de) 2001-04-15
PL185755B1 (pl) 2003-07-31

Similar Documents

Publication Publication Date Title
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO972211D0 (no) Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene
DK0825178T3 (da) Phenylsubstituerede alkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO980273D0 (no) Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO960364L (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO964053D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK303688D0 (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO984476L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO972527L (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende benzoylguanidinene
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO970697L (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
NO985023D0 (no) Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
DK0754680T3 (da) 4-Fluoralkyl-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO954739D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene
NO964812D0 (no) Sulfonylamino-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO983577D0 (no) Sulfonamidsubstituerte forbindelser, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
NO984475L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO972793D0 (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK225189D0 (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO972406D0 (no) Bis-orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO980564L (no) Sulfonamid-substituerte forbindelser, fremgangsmÕte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnÕdd medikament er beskrevet

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees